RSS

cancer research

The Alliance Foundation Trials (AFT) — in conjunction with Pfizer and six international cancer research groups — has launched a randomised open-label Phase III clinical study, PATINA, to evaluate a combination therapy for breast cancer. more

News

Scientists have identified a chemical compound that is highly effective at blocking the growth of breast cancer cells. more

News

A patient in Manchester is the first to take part in a pioneering cancer trial. more

News

An award to progress a lung cancer candidate into the clinic has been given to Queen’s University Belfast and Domainex more

News

breast-cancer-cells-stained-for-dna-(red)-nfkb-(green)-and-a-reactive-oxygen-species-probe-(blue)-julia-sero-the-icr-2011.jpg

photo: Julia Sero/the ICR

A combination of lapatinib and trastuzumab (Herceptin) before surgery shrinks and may even destroy tumours in women with HER2 positive disease within 11 days, according to new research more

News

Implantable device delivers treatment for pancreatic cancer directly to tumours, bypassing bloodstream and limiting widespread side effects, according to The University of North Carolina (UNC) more

News

Pharma companies have been teaming up in the fight against cancer. EPM lists the top 5 cancer fighting collaborations more

Opinion

The US Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) and granted Priority Review for Genentech’s venetoclax for the treatment of chronic lymphocytic leukaemia (CLL) more

News

Lenvatinib, discovered and developed by Eisai, has been submitted for review by the European Medicines Agency (EMA) for use in combination with everolimus to treat people with metastatic kidney cancer more

News

Novartis has announced a strategic alliance and licensing agreement with Surface Oncology to grow its immune-oncology pipeline more

News

Kymab and MD Anderson Cancer Centre have announced a strategic cancer drug discovery and development alliance more

News

OSE Pharma has selected 70 international clinical centres to participate in its pivotal phase three clinical trial of Tedopi for patients diagnosed with advanced non-small cell lung cancer (NSCLC) more

News

The treatment market for pancreatic cancer is set to grow from its current level of £1.2bn ($1.9bn) to an impressive £1.9bn ($2.9bn) by 2021 more

News

Scientists at the Technical University of Munich (TUM) have developed a small, highly active molecule that binds to a specific integrin which operates in many types of cancer more

News

Voluntis and AstraZeneca have announced plans to test a digital support service for women undergoing treatment for recurrent platinum-sensitive high-grade ovarian cancer in clinical trials of cediranib plus olaparib more

News

Sanofi and BioNTech have entered into a research collaboration and license agreement to develop up to five cancer immunotherapies more

News

As October is Breast Cancer Awareness month EPM has put together a list of medical developments and partnerships in the pharmaceutical sector that are helping to treat cancer more

Opinion

A study published in Cell shows a class of experimental drug treatments that could help the body’s immune system fight cancer and is already in clinical trials more

News

Cancer Research UK’s Drug Discovery Committee has awarded Newcastle University’s Northern Institute of Cancer Research £5 million to bring more cancer drugs to clinical trials. more

News

Following the successful launch of its PIPETGIRL pink pipette controller in support of breast cancer research, INTEGRA Biosciences has made a $10,000 donation to the Susan F Smith Center for Womens Cancers at the Dana-Farber Cancer Institute. more

News